ET-901 is under clinical development by EdiGene and currently in Phase II for B-Cell Non-Hodgkin Lymphoma. According to GlobalData, Phase II drugs for B-Cell Non-Hodgkin Lymphoma have a 36% phase ...
VVD-130850 is under clinical development by Vividion Therapeutics and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData, Phase I drugs for Non-Hodgkin Lymphoma have a 71% phase ...
Non-Hodgkin lymphoma (NHL) is a blood cancer that occurs when malignant cells develop in the lymphatic system. (Image Credits: Pixabay) Immuneel Therapeutics on Monday launched Qartemi ...
Recent years have witnessed notable progress in tailoring treatments for solid tumors using biomarkers. Nevertheless, identifying specific biomarkers for ...
There are two types of lymphoma: Hodgkin lymphoma is the less common type of lymphoma. It is distinguished by the presence of cells called Reed-Sternberg cells. Non-Hodgkin lymphoma is the most common ...